|
SABSW SAB Biotherapeutics 1833214 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-22,491,000.00 |
| Balance Sheet |
|
Current Assets
|
$107,937,000.00 |
|
Assets
|
$238,210,000.00 |
|
Current Liabilities
|
$11,705,000.00 |
|
Liabilities
|
$23,425,000.00 |
|
Equity
|
$214,785,000.00 |
|
Shares Out
|
83493068.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,112,000.00 |
|
Investing Cash Flow
|
$-70,531,000.00 |
| Market Analysis |
Market Cap
|
$2,504,792.04 |
|
Price
|
$0.03 |
|
BVPS
|
2.57 |
|
PB
|
0.01 |
|
EPS
|
-0.28 |
|
FCF
|
$-26,681,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:10 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SABSW documents filed with the SEC.
SABSW Filings
Clear
